Cargando…

The role of preoperative inflammatory markers in patients with central nervous system tumors, focus on glioma

BACKGROUND: CNS tumors, particularly gliomas, are associated with a high rate of disability and lethality, and are typically diagnosed with histopathology and immunohistochemistry. Our research aims to develop a minimally invasive method for diagnosing, grading and molecular typing glioma. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Fan, Chao, Min, Huang, Tao, Guo, Shaochun, Zhai, Yulong, Wang, Yuan, Wang, Na, Xie, Xuan, Wang, Liang, Ji, Peigang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9723353/ https://www.ncbi.nlm.nih.gov/pubmed/36483052 http://dx.doi.org/10.3389/fonc.2022.1055783

Ejemplares similares

The clinical and neurocognitive functional changes with awake brain mapping for gliomas invading eloquent areas: Institutional experience and the utility of The Montreal Cognitive Assessment
por: Wang, Yuan, et al.
Publicado: (2023)

Molecular Pathological Markers Correlated With the Recurrence Patterns of Glioma
por: Ge, Shunnan, et al.
Publicado: (2021)

Prognostic and predictive factors of secondary gliosarcoma: A single-institution series of 18 cases combined with 89 cases from literature
por: Liu, Jinghui, et al.
Publicado: (2023)

Clinical updates on gliomas and implications of the 5th edition of the WHO classification of central nervous system tumors
por: Guo, Xiaopeng, et al.
Publicado: (2023)

Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study
por: Wang, Yixi, et al.
Publicado: (2019)

Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer
por: Xiao, Zilong, et al.
Publicado: (2023)

Early Unplanned Reoperation After Glioma Craniotomy: Incidence, Predictor and Process Improvement
por: Zhang, Yu, et al.
Publicado: (2022)

Relapsed Primary Central Nervous System Lymphoma: Current Advances
por: Tao, Kaiyan, et al.
Publicado: (2021)

Prognostic Values of Preoperative Inflammatory and Nutritional Markers for Colorectal Cancer
por: Zhang, Nannan, et al.
Publicado: (2020)

Radiomics Analysis of Postoperative Epilepsy Seizures in Low-Grade Gliomas Using Preoperative MR Images
por: Sun, Kai, et al.
Publicado: (2020)

Preoperative Prediction Nomogram Based on Integrated Profiling for Glioblastoma Multiforme in Glioma Patients
por: Wu, Wei, et al.
Publicado: (2020)

Preoperative Radiomics Analysis of 1p/19q Status in WHO Grade II Gliomas
por: Fan, Ziwen, et al.
Publicado: (2021)

Pathogenesis of central nervous system germ cell tumors
por: Liu, Siyuan, et al.
Publicado: (2022)

Correlation between preoperative inflammatory markers, Ki-67 and the pathological grade of glioma
por: Xu, Guangda, et al.
Publicado: (2021)

A Deep Learning Model for Preoperative Differentiation of Glioblastoma, Brain Metastasis and Primary Central Nervous System Lymphoma: A Pilot Study
por: Tariciotti, Leonardo, et al.
Publicado: (2022)

A Radiomics Model for Predicting Early Recurrence in Grade II Gliomas Based on Preoperative Multiparametric Magnetic Resonance Imaging
por: Wang, Zhen-hua, et al.
Publicado: (2021)

The Prognostic Value of Preoperative Systemic Inflammatory Response Index (SIRI) in Patients With High-Grade Glioma and the Establishment of a Nomogram
por: He, Qian, et al.
Publicado: (2021)

Clinical Features and Molecular Markers on Diffuse Midline Gliomas With H3K27M Mutations: A 43 Cases Retrospective Cohort Study
por: Wang, Yuan, et al.
Publicado: (2021)

Efficiency of Crizotinib on an ALK-Positive Inflammatory Myofibroblastic Tumor of the Central Nervous System: A Case Report
por: Chennouf, Anas, et al.
Publicado: (2017)

ELK3: A New Molecular Marker for the Diagnosis and Prognosis of Glioma
por: Liu, Zhendong, et al.
Publicado: (2021)

Beyond the Blood:Brain Barrier: The Importance of Central Nervous System (CNS) Pharmacokinetics for the Treatment of CNS Tumors, Including Diffuse Intrinsic Pontine Glioma
por: Warren, Katherine Elizabeth
Publicado: (2018)

Association of preoperative levels of selected blood inflammatory markers with prognosis in gliomas
por: Auezova, Raushan, et al.
Publicado: (2016)

Analysis of Cellular Heterogeneity in Immune Microenvironment of Primary Central Nervous System Lymphoma by Single-Cell Sequencing
por: Wei, Boyuan, et al.
Publicado: (2021)

Single-Cell Sequencing of Glioblastoma Reveals Central Nervous System Susceptibility to SARS-CoV-2
por: Wu, Bingshan, et al.
Publicado: (2020)

Impact of the Extent of Surgical Resection on Patients With Intradural Extramedullary Bronchogenic Cysts: A Retrospective Institutional Experience and Review of the Literature
por: Liu, Jinghui, et al.
Publicado: (2021)

GNG12 as A Novel Molecular Marker for the Diagnosis and Treatment of Glioma
por: Liu, Runze, et al.
Publicado: (2022)

Prognostic Role of Blood Markers in Primary Central Nervous System Lymphoma Patients Treated With High-Dose Methotrexate-Based Therapy
por: Luo, Qian, et al.
Publicado: (2021)

A novel inflammation-related prognostic model for predicting the overall survival of primary central nervous system lymphoma: A real-world data analysis
por: Wu, Zhentian, et al.
Publicado: (2023)

Epidemiologic Characteristics, Prognostic Factors, and Treatment Outcomes in Primary Central Nervous System Lymphoma: A SEER-Based Study
por: Tang, Dongsheng, et al.
Publicado: (2022)

BRAF Alteration in Central and Peripheral Nervous System Tumors
por: Srinivasa, Komal, et al.
Publicado: (2020)

Primary Central Nervous System Lymphoma With Systemic Recurrence
por: Pandravada, Sasirekha, et al.
Publicado: (2021)

ErbB4 in the brain: Focus on high grade glioma
por: Pitcher, Jamie-Lee, et al.
Publicado: (2022)

Factors Involved in Preoperative Edema in High-Grade Gliomas
por: Saito, Takashi, et al.
Publicado: (2022)

Epidemiological characteristics for patients with traumatic brain injury and the nomogram model for poor prognosis: an 18-year hospital-based study
por: Guo, Shaochun, et al.
Publicado: (2023)

Prognostic value of preoperative hematological markers combined with molecular pathology in patients with diffuse gliomas
por: Zhang, Zhen-Yu, et al.
Publicado: (2019)

Immune Responses to Non-Tumor Antigens in the Central Nervous System
por: Huber, Amanda K., et al.
Publicado: (2014)

Editorial: Mechanisms and Therapy for Cancer Metastasis to the Central Nervous System
por: Zhao, Haotian, et al.
Publicado: (2019)

Rare Primary Central Nervous System Tumors in Adults: An Overview
por: Franceschi, Enrico, et al.
Publicado: (2020)

Editorial: Advances in the treatment of primary central nervous system lymphoma
por: Qian, Liren, et al.
Publicado: (2023)

NK Cell-Based Immunotherapy and Therapeutic Perspective in Gliomas
por: Pan, Changqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jgnmp24e7371djldcrn9prnrln